ASP Isotopes Inc. specializes in development and production of nuclear isotopes using proprietary separation technology, focusing on nuclear, medical, and scientific applications.

# Company Overview - ASP Isotopes Inc.

**Company Name:** ASP Isotopes Inc.  
**Location:** 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004  
**Stock Listing:** Nasdaq Capital Market LLC (Trading Symbol: ASPI)  
**Fiscal Year End:** December 31, 2024  
**Incorporation:** Delaware, USA  
**IRS Employer ID:** 87-2618235  

---

## Core Business Activities
ASP Isotopes Inc. specializes in the development and commercial production of nuclear isotopes and related technology. The company is focused on isotope separation technology, particularly chemical and nuclear applications, including producing isotopes like HALEU (High-Assay Low-Enriched Uranium) and Lithium-6. Their technology, known as the "Aerodynamic Separation Process" (ASP), was co-developed by the company's Chief Technology Officer, Hendrik Strydom.

## Key Technologies & Operations
- **ASP (Aerodynamic Separation Process):** A proprietary isotope separation technology developed for separating silicon, carbon, oxygen, molybdenum, and other isotopes.
- **Focus Areas:** Nuclear fuel manufacturing, medical radioisotope production, scientific research, and potentially strategic reserves.
- **Subsidiaries:** Includes ASP Isotopes UK Limited and ASP Isotopes South Africa (Proprietary) Limited.

## Customers and Market
- No specific number of customers is provided.
- The company engages in strategic negotiations for joint ventures, collaborations, and key strategic transactions, indicating ongoing business development efforts.

## Employees
- The company’s leadership team includes a small executive team with key figures such as:
  - **Paul Mann:** Chairman and CEO, age 49
  - **Heather Kiessling:** CFO, age 60
  - **Robert Ainscow:** COO, age 49
  - **Hendrik Strydom:** CTO, age 64
- The total number of employees is not explicitly given.

## Financial Data (Based on 2024)
- **Revenue:** Not specified.
- **Net Income:** Not specified.
- **Number of Shares Outstanding:** Approximately 75,061,842 as of March 31, 2025.
- **Market Capitalization:** Not provided; the aggregate market value of voting stock held by non-affiliates as of June 30, 2024, was approximately $million (exact amount not specified).

## Corporate Governance & Structure
- The board of directors includes six members, with extensive expertise in science, finance, biotech, and international markets.
- The company has established standard committees: Audit, Compensation, Nominating and Governance, and Special Projects.
- The company maintains a written code of conduct and has policies around related-party transactions and insider trading.

---

## Summary
ASP Isotopes Inc. is a U.S.-based biotechnology and nuclear technology company focusing on isotope separation and advanced nuclear fuel production. It leverages proprietary ASP technology to produce isotopes used in nuclear power, scientific research, and medical applications. The company is still in an expansion and development phase, with no publicly disclosed revenue or income figures, and operates with a relatively small executive team without publicly available specifics on total employee count or customer base.

ASP Isotopes Inc. is a Delaware-based company specializing in the production and supply of isotopes for medical applications, focusing on advanced technology for isotope enrichment.

# Company Overview: ASP Isotopes Inc.

ASP Isotopes Inc. is a Delaware-based company primarily focused on the production and supply of isotopes for various applications, particularly in the medical field, including nuclear medicine. The company's mission revolves around developing advanced technologies to enrich isotopes, which can be utilized for diagnostic and therapeutic procedures.

## Business Focus

- **Isotope Production:** ASP Isotopes specializes in the enrichment of isotopes, which play a crucial role in medical imaging and radiotherapy.
- **Research and Development:** The company is actively involved in R&D to improve isotope production techniques and expand their applications.
- **Licensing and Partnerships:** ASP Isotopes engages in strategic partnerships and licensing agreements to enhance its market reach and operational capabilities.

## Operations & Structure

- **Size and Scale:**
  - **Employees:** As of the last reporting, the company employs a dedicated workforce, although specific numbers of employees were not disclosed.
  - **Facilities:** The company operates in specialized facilities designed to safely produce and handle radioactive materials.

## Financial Performance

Unfortunately, specific revenue and income figures for ASP Isotopes are not provided in the amendment document. However, references indicate that the company is in the growth phase, moving from a private company to a public entity, which entails investments in infrastructure and personnel.

## Market Position and Clients

- **Customer Base:** ASP Isotopes serves a diverse clientele primarily across the healthcare sector, including hospitals, research institutions, and diagnostic imaging centers.
- **Market Growth:** The increasing demand for isotopes in medical applications is a significant driver for the company, given the rising trends in nuclear medicine and diagnostics.

## Summary

ASP Isotopes Inc. is poised as a growing player in the isotope market, focusing on innovative production methods and expanding its presence through strategic partnerships. While detailed numerical data regarding customers, employees, revenue, and income are not included in the filing, the company aims for significant advancements and operational efficiencies to meet the increased global demand for medical isotopes.

ASP Isotopes Inc.

10-K / April 30, 2025

10-K / July 1, 2024

10-K / April 30, 2025

Company Overview - ASP Isotopes Inc.

Core Business Activities

Key Technologies & Operations

Customers and Market

Employees

Financial Data (Based on 2024)

Corporate Governance & Structure

Summary